6-K

Commission File Number 001-31914

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

December 30, 2019

China Life Insurance Company Limited

(Translation of registrant’s name into English)

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  ☒             Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ___________

Commission File Number 001-31914

China Life Insurance Company Limited issued an announcement on December 30, 2019, a copy of which is attached as Exhibit 99.1 hereto.

EXHIBIT LIST

Exhibit	Description
99.1	Announcement, dated December 30, 2019

Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		China Life Insurance Company Limited
		(Registrant)
December 30, 2019	By:	/s/ Su Hengxuan
		(Signature)
	Name:	Su Hengxuan
	Title:	President and Executive Director

EX-99.1

Commission File Number 001-31914

EXHIBIT 99.1

ANNOUNCEMENT ON THE PROGRESS

OF CONNECTED TRANSACTION IN RELATION TO

THE FORMATION OF PARTNERSHIP

Reference is made to the announcement of China Life Insurance Company Limited (the “Company”) dated 23 July 2019 (the “Announcement”) in relation to a connected transaction concerning the formation of the Partnership between the Company and other investors (each as a Limited Partner) and Xiongan Fund Management and CLIIM (each as a General Partner). Unless the context otherwise requires, the terms used herein shall have the same meanings as those defined in the Announcement.

As disclosed in the Announcement, the parties intended to enter into the Partnership Agreement by 31 December 2019. As there may be changes in the investors of the Partnership, the size of the Partnership may decrease, and corresponding amendments may need to be made to the terms of the Partnership Agreement, the parties will not be able to enter into the Partnership Agreement by 31 December 2019 as originally planned. The Company will make a further announcement when the terms of the Partnership Agreement are finalized by the parties.

By Order of the Board

China Life Insurance Company Limited

Heng Victor Ja Wei

Company Secretary

Hong Kong, 30 December 2019

As at the date of this announcement, the Board of the Company comprises:

Executive Directors:	Wang Bin, Su Hengxuan, Li Mingguang
Non-executive Directors:	Yuan Changqing, Liu Huimin, Yin Zhaojun, Wang Junhui
Independent Non-executive Directors:	Chang Tso Tung Stephen, Robinson Drake Pike, Tang Xin, Leung Oi-Sie Elsie